Ghasaq Saleh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ghasaq Saleh has a total of 45 co-authors. Here are the top co-authors by number of shared publications:
- Mohamad Alkhouli
Mayo Clinic
6 shared publications - Abdullah Al-Abcha
Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA
3 shared publications Rajiv Gulati
3 shared publicationsTrevor Simard
Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA
3 shared publications- Fadi W. Adel
Department of Cardiovascular Medicine, Mayo Clinic
2 shared publications Mahmoud Zhour Adi
2 shared publications
Latest Publications
- Open Access
- 27 August 2026
- Published by Oxford University Press (OUP) in European Heart Journal - Case Reports
- Vol. 10 (9)
Cardinal lessons in cardiac amyloidosis: diagnostic pitfalls across three cases—a case report
Background: Cardiac amyloidosis (CA) is an infiltrative cardiomyopathy caused by extracellular deposition of misfolded amyloid fibrils within the myocardium, resulting in progressive ventricular wall thickening and heart failure. Transthyretin (ATTR) and immunoglobulin light-chain (AL) amyloidosis account for ∼95% of cases. Despite advances in diagnostic imaging and laboratory testing, CA remains underrecognized, often leading to misdiagnosis or delayed diagnosis. Timely and accurate diagnosis, including amyloid subtyping, is critical to guide appropriate therapy and improve clinical outcomes, as prognosis and management vary substantially among amyloid subtypes. Case summary: We present a three-case series illustrating distinct diagnostic and clinical challenges in CA, including a false-positive diagnosis of ATTR cardiomyopathy (ATTR-CM) based on planar technetium-99m pyrophosphate (PYP) scintigraphy that was subsequently ruled out by single-photon emission computed tomography (SPECT) imaging and further evaluation, a delayed diagnosis of AL amyloidosis in a patient with progressive heart failure initially attributed to non-ischaemic cardiomyopathy, and recurrent left atrial appendage thrombus despite therapeutic anticoagulation in a patient with AL amyloidosis. Discussion: These three cases demonstrate the broad spectrum of diagnostic and clinical challenges encountered in CA. The first case underscores the importance of SPECT imaging in differentiating true myocardial radiotracer uptake from blood pool activity, a common source of false-positive planar PYP studies. The second emphasizes the critical role of comprehensive monoclonal protein screening in patients with suspected amyloidosis as delayed diagnosis of AL amyloidosis may adversely affect outcomes. The third illustrates the heightened thromboembolic risk associated with CA, even in the setting of therapeutic anticoagulation, and supports consideration of transoesophageal echocardiography before cardioversion in this high-risk population.
- 27 August 2026
- Published by Oxford University Press (OUP) in European Heart Journal - Case Reports
- Vol. 10 (9)
Open AccessCardinal lessons in cardiac amyloidosis: diagnostic pitfalls across three cases—a case report
Background: Cardiac amyloidosis (CA) is an infiltrative cardiomyopathy caused by extracellular deposition of misfolded amyloid fibrils within the myocardium, resulting in progressive ventricular wall thickening and heart failure. Transthyretin (ATTR) and immunoglobulin light-chain (AL) amyloidosis account for ∼95% of cases. Despite advances in diagnostic imaging and laboratory testing, CA remains underrecognized, often leading to misdiagnosis or delayed diagnosis. Timely and accurate diagnosis, including amyloid subtyping, is critical to guide appropriate therapy and improve clinical outcomes, as prognosis and management vary substantially among amyloid subtypes. Case summary: We present a three-case series illustrating distinct diagnostic and clinical challenges in CA, including a false-positive diagnosis of ATTR cardiomyopathy (ATTR-CM) based on planar technetium-99m pyrophosphate (PYP) scintigraphy that was subsequently ruled out by single-photon emission computed tomography (SPECT) imaging and further evaluation, a delayed diagnosis of AL amyloidosis in a patient with progressive heart failure initially attributed to non-ischaemic cardiomyopathy, and recurrent left atrial appendage thrombus despite therapeutic anticoagulation in a patient with AL amyloidosis. Discussion: These three cases demonstrate the broad spectrum of diagnostic and clinical challenges encountered in CA. The first case underscores the importance of SPECT imaging in differentiating true myocardial radiotracer uptake from blood pool activity, a common source of false-positive planar PYP studies. The second emphasizes the critical role of comprehensive monoclonal protein screening in patients with suspected amyloidosis as delayed diagnosis of AL amyloidosis may adversely affect outcomes. The third illustrates the heightened thromboembolic risk associated with CA, even in the setting of therapeutic anticoagulation, and supports consideration of transoesophageal echocardiography before cardioversion in this high-risk population.
- Open Access
- 23 July 2026
- Published by Elsevier in JACC: Advances
- Vol. 5 (8) , 103057
Natural History and Outcomes of Patients With Moderate and Moderate-Severe Mitral Regurgitation
- 23 July 2026
- Published by Elsevier in JACC: Advances
- Vol. 5 (8) , 103057
Open AccessNatural History and Outcomes of Patients With Moderate and Moderate-Severe Mitral Regurgitation
- 15 October 2025
- Published by Elsevier in JACC: Cardiovascular Interventions
- Vol. 18 (21) , 2614-2624
Outcomes of Stroke Prevention Strategies in Patients With Atrial Fibrillation and End-Stage Renal Disease
- 15 October 2025
- Published by Elsevier in JACC: Cardiovascular Interventions
- Vol. 18 (21) , 2614-2624
Outcomes of Stroke Prevention Strategies in Patients With Atrial Fibrillation and End-Stage Renal Disease
- Open Access
- 1 October 2025
- Published by Elsevier in JACC: Case Reports
- Vol. 30 (30) , 105307
Delayed-Onset ICI-Associated Myocarditis
- 1 October 2025
- Published by Elsevier in JACC: Case Reports
- Vol. 30 (30) , 105307
Open AccessDelayed-Onset ICI-Associated Myocarditis
- Open Access
- 22 August 2025
- Published by Elsevier in JACC: Advances
- Vol. 4 (9) , 102090
Prospective Evaluation of the Impact of Sedation During LAAO on Cognitive Function Using Oculomotor Biomarkers
- 22 August 2025
- Published by Elsevier in JACC: Advances
- Vol. 4 (9) , 102090
Open AccessProspective Evaluation of the Impact of Sedation During LAAO on Cognitive Function Using Oculomotor Biomarkers
- 5 August 2025
- Published by Elsevier in JACC: Cardiovascular Imaging
- Vol. 18 (10) , 1161-1166
Concomitant Takotsubo Cardiomyopathy and Spontaneous Coronary Artery Dissection
- 5 August 2025
- Published by Elsevier in JACC: Cardiovascular Imaging
- Vol. 18 (10) , 1161-1166
Concomitant Takotsubo Cardiomyopathy and Spontaneous Coronary Artery Dissection
- 23 July 2025
- Published by Elsevier in JACC: Cardiovascular Interventions
- Vol. 18 (17) , 2183-2185
Using Temporary Balloon Occlusion of Chest Wall Branches to Determine the Impact of Coil Embolization on LIMA Graft Flow
- 23 July 2025
- Published by Elsevier in JACC: Cardiovascular Interventions
- Vol. 18 (17) , 2183-2185
Using Temporary Balloon Occlusion of Chest Wall Branches to Determine the Impact of Coil Embolization on LIMA Graft Flow
- Open Access
- 23 August 2024
- Published by Elsevier in JACC: Advances
- Vol. 3 (9) , 101171
Artificial Intelligence Electrocardiogram-Derived Heart Age Predicts Long-Term Mortality After Transcatheter Aortic Valve Replacement
- 23 August 2024
- Published by Elsevier in JACC: Advances
- Vol. 3 (9) , 101171
Open AccessArtificial Intelligence Electrocardiogram-Derived Heart Age Predicts Long-Term Mortality After Transcatheter Aortic Valve Replacement
- Open Access
- 1 January 2023
- Published by Wiley in Case Reports in Pediatrics
- Vol. 2023 (1) , 3535164
Intussusception in a 4‐Year‐Old Male Due to Burkitt Lymphoma
Intussusception is the invagination of a proximal bowel segment into a distal segment causing bowel obstruction, especially in children. In some cases, it can be caused by a pathological lead point, such as Burkitt lymphoma. Burkitt lymphoma has several patterns of clinical presentations, such as jaw or facial bone tumor in the endemic form, in contrast to an abdominal presentation most often with massive disease and ascites. We describe a case of a 4‐year‐old male who presented bowel obstruction. Using X‐ray and ultrasound findings, ileocecal intussusception was then diagnosed. Resection and anastomosis was performed after multiple trials of failed hydrostatic reduction. On the pathology report of the resected segment, Burkitt lymphoma was found to be the cause and chemotherapy was initiated. The patient is doing well and is following up every 6 months for 2 years. A pathological lead point, especially Burkitt lymphoma, should be suspected in patients with failed conservative treatment, and prompt diagnosis of the pathology should be performed to prevent further sequela of the disease.
- 1 January 2023
- Published by Wiley in Case Reports in Pediatrics
- Vol. 2023 (1) , 3535164
Open AccessIntussusception in a 4‐Year‐Old Male Due to Burkitt Lymphoma
Intussusception is the invagination of a proximal bowel segment into a distal segment causing bowel obstruction, especially in children. In some cases, it can be caused by a pathological lead point, such as Burkitt lymphoma. Burkitt lymphoma has several patterns of clinical presentations, such as jaw or facial bone tumor in the endemic form, in contrast to an abdominal presentation most often with massive disease and ascites. We describe a case of a 4‐year‐old male who presented bowel obstruction. Using X‐ray and ultrasound findings, ileocecal intussusception was then diagnosed. Resection and anastomosis was performed after multiple trials of failed hydrostatic reduction. On the pathology report of the resected segment, Burkitt lymphoma was found to be the cause and chemotherapy was initiated. The patient is doing well and is following up every 6 months for 2 years. A pathological lead point, especially Burkitt lymphoma, should be suspected in patients with failed conservative treatment, and prompt diagnosis of the pathology should be performed to prevent further sequela of the disease.